Orphan Drugs in the U.S.
Presentation by Dr. John Doyle, Market Access Practice Leader, from ISPOR 14th Annual International Meeting 2009(International Society for Pharmacoeconomics and Outcomes Research) on “Orphan Drugs' Market Access in the U.S.” During this presentation on orphan drugs, Dr. Doyle assesses possible hurdles to patient access and drug utilization- including out of pocket costs.
